"Superiority of Carboplatin-Based Doublet Chemotherapy Regimens to ..."

Elizabeth Lamont et al. (2016)

> Home

Details and statistics

DOI: —

access: closed

type: Conference or Workshop Paper

metadata version: 2024-04-17

- view
  - electronic edition @ amia.org (archived)
- export record
  dblp key:
  - conf/amia/LamontKAL16
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/amia/LamontKAL16
Elizabeth Lamont, Nancy Keating, Christopher Azzoli, Mary Beth Landrum:
Superiority of Carboplatin-Based Doublet Chemotherapy Regimens to Cisplatin-Based Doublet Chemotherapy Regimens among a Cohort of Medicare Patients Aged 70 and Older with Stage IV Non-Small Cell Lung Cancer. AMIA 2016

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.